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SUMMARY
This study examines the timing of menarche in relation to infant feeding methods, specifically
addressing the potential effects of soy isoflavone exposure through soy-based infant feeding.
Subjects were participants in the Avon Longitudinal Study of Parents and Children (ALSPAC).
Mothers were enrolled during pregnancy and their children have been followed prospectively.
Early life feeding regimes, categorized as primarily breast, early formula, early soy, and late soy
were defined using infant feeding questionnaires administered during infancy. For this analysis,
age at menarche was assessed through questionnaires administered approximately annually
between ages 8 and 14.5. Eligible subjects were limited to term, singleton, white females. We used
Kaplan-Meier survival curves and Cox proportional hazards models to assess age at menarche and
risk of menarche over the study period.
The present analysis included 2,920 girls. Approximately 2% of mothers reported that soy
products were introduced into the infant diet at or before 4 months of age (early soy). The median
age at menarche [interquartile range (IQR)] in the study sample was 153 months [144–163],
approximately 12.8 years. The median age at menarche among early soy fed girls was 149 months
(12.4 years) [IQR, 140–159]. Compared to girls fed non-soy based infant formula or milk (early
formula), early soy fed girls were at 25% higher risk of menarche throughout the course of follow
up (Hazard Ratio 1.25 [95% confidence interval, 0.92, 1.71]). Our results also suggest that girls
fed soy products in early infancy may have an increased risk of menarche specifically in early
adolescence. These findings may be the observable manifestation of mild endocrine disrupting
effects of soy isoflavone exposure. However, our study is limited by few soy-exposed subjects and
is not designed to assess biological mechanisms. Because soy formula use is common in some
populations, this subtle association with menarche warrants more indepth evaluation in future
studies.
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Some of the soy isoflavones, specifically genistein and daidzein, are weak estrogenic
compounds that are present in soy protein and various products derived from soybeans.1–3
Demonstrating structural and functional similarity to 17β-estradiol, soy isoflavones can bind
to estrogen receptors and can act as either estrogen agonists or antagonists.4–6 The biological
activity of soy isoflavones has been demonstrated widely in vitro and in animal models,7–11
as well as in adult humans.12, 13 Few studies, however, have addressed the effects of early
life soy protein exposure on long-term outcomes such as reproductive development and
function.
The timing of puberty, or the transition from childhood to the adult reproductive stage, is a
complex process hypothesized to be determined, in part, by early life endocrine system
function.14 Accordingly, exposure to soy isoflavones in early infancy may have lasting
effects on later reproductive development. Animal studies have shown that pubertal markers,
such as the age at vaginal opening, occur earlier in female rodents fed genistein or a soy
based diet during various time points in early development.15–18 Early pubertal onset has
also been observed in girls exposed to other endocrine disrupting compounds pre- and
postnatally.19, 20 Overall, however, epidemiologic studies on the effects of early life
endocrine disruptor exposure on the timing of puberty have been equivocal.21–24
Infants exposed to soy-based products, such as soy-based infant formula (SBF), have not
been well studied with respect to potentially endocrine disrupting effects of early life soy
exposure. SBF is commonly used in the United States, accounting for approximately 12–
20% of the infant formula sold.25, 26 The urinary concentration of total isoflavones among
infants exclusively fed SBF is approximately 500 times the concentration of those fed cow’s
milk formula,27 and plasma isoflavone concentrations per bodyweight are an order of
magnitude higher in SBF fed infants than in adults consuming diets containing soy
protein.28 We have investigated the association between soy product use during early
infancy and age at menarche among girls enrolled in the Avon Longitudinal Study of
Parents and Children (ALSPAC). In this study, age at menarche may serve as an easily
observable marker of early life endocrine disruption.
METHODS
Study Sample
ALSPAC is an ongoing, prospective, longitudinal study that enrolled pregnant women
residing in the Avon region of the United Kingdom, who were expected to deliver between
April 1, 1991 and December 31, 1992. 14,062 live births were recruited into the study
during pregnancy. Of these, 13,978 (52% boys and 48% girls) were twins or singletons alive
at one year. Mothers provided consent for participation. Ethical approval for the study was
obtained from the ALSPAC Law and Ethics Committee and the local Research Ethics
Committees and the present analysis was approved by the Institutional Review Board of the
University of North Carolina at Chapel Hill.
The present investigation was restricted to singleton, term, white females (n = 5,230), then
further restricted to those for whom sufficient infant feeding data were available and for
whom at least one puberty questionnaire was completed between the ages of approximately
8 and 14.5 years of age (n = 2,920). We restricted the analysis to white girls because over
90% of the study sample was white, which limited our ability to control confounding by
race.
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Exposure assessment methods have been described previously.29 In brief, mothers
completed infant feeding questionnaires at 1, 6, 15 and 24 months postpartum in which they
reported current breast-feeding habits, the age at which other milks or formulas were
introduced into the child’s diet (including formula/baby milk, soy milk, soy formula, follow-
on milk, goat’s milk, hypo-allergenic formula, and cow’s milk), and how many feedings per
week were given for each product at the time of questionnaire completion.
Exposure classification was defined by responses to the questionnaire administered at 6
months postpartum, since this questionnaire most thoroughly and proximally characterized
feeding behaviors in early infancy. Responses from the 15-month questionnaire were used to
characterize these early exposures if the 6 month questionnaire was missing or incomplete,
as well as to characterize exposures later in infancy. Subjects were categorized into four
mutually exclusive feeding groups: primarily breast-fed, early formula, early soy, and late
soy (Figure 1). Primarily breast-fed infants were breast fed until ≥ 6 months of age, had no
reported soy use between birth and 24 months and no reported introduction of other milks or
formulas before 6 months of age. Early formula fed infants were introduced to any non-soy
milk or formula product at or before 4 months of age, sustained use of such products at 6
months of age, and had no reported soy use before 24 months. Early soy fed infants were
introduced to soy milk or soy formula at or before 4 months of age, and sustained use at 6
months of age. Late soy fed infants were introduced to soy milk or soy formula any time
after 4 months of age through 15 months of age. For the early formula and early soy
exposure groups, the minimum exposure window of 4–6 months of age was defined as such
in order to capture a period in infancy where the diet was predominantly milk-based, and
also to allow for sufficient sample size to be included in each exposure group. Subjects were
excluded if feeding profiles were not sufficiently complete to estimate duration of a
particular feeding method, or if feeding profile did not fit in a previously described exposure
category. Subjects who only reported soy use between 16 and 24 months were also excluded
because it was assumed that exposure would be low compared to the earlier time periods
when milk or formula comprised most of the diet. No restrictions were made in the early
formula, early soy, and late soy groups with respect to duration of breast feeding; likewise,
there were no restrictions in the early soy or late soy groups with respect to use of non-soy
milk or formula. Exposure definitions do not take into account exposure to solid foods and
their corresponding soy content, if any.
Outcome assessment
Between 1999 and 2007, a series of questionnaires regarding pubertal development (the
“Growing and Changing” questionnaires), were administered at approximately 8, 9.5, 10.5,
11.5,13 and 14.5 years (y) of age.30 Questionnaires were completed by a care-giving adult or
the child of interest. In each questionnaire, subjects were asked if the child had had her first
period, and if so, what month and year her first period occurred. Her age at menarche was
defined as her age in months at this time. If multiple questionnaires contained discordant age
at menarche responses for the same individual (n=528, 18%), the response that was provided
first in the series of Growing and Changing questionnaires was used as the girl’s age at
menarche. ALSPAC subjects were also invited to attend regular research clinic visits, where
age at menarche, among other developmental characteristics, was assessed. For 138 (4.7%)
subjects in the present analysis, missing questionnaire data on age at menarche were
estimated from this clinic data.
Some subjects reported a menarche event, but did not report an age at menarche (n = 99).
For 60 of these subjects, age at menarche was estimated as the midpoint between the age at
which the questionnaire with the first positive menarche response was completed, and the
Adgent et al. Page 3













age at which the previous year’s questionnaire was completed. If one or more questionnaire
was skipped between a negative and positive menarche response, an estimated age was not
derived and this subject was not included in any analysis (n = 39). In an alternative analysis,
age at menarche was imputed for these 60 subjects as part of a larger multiple imputation
exercise (described below). Ages derived using the midpoint approach were included in the
complete case analysis, while imputed values were used in multiple imputation models only.
Analysis
All analyses were completed using SAS 9.1.3 and 9.2 (SAS Institute Inc., Cary, NC). Chi-
square tests and t-tests (α = 0.05) were used to compare the distribution of covariates
between included and excluded subjects, and between exposure groups. Time-to-event
analyses were used to assess differences in age at menarche between exposure groups.
Follow- up time was defined for each subject based on the age in months at which she
reported a menarche event (events), or the age of the last completed questionnaire in which
she reported not having reached menarche (censored). Censored subjects (those that did not
report a menarche event) were distinguished as either lost to follow up (LTF) (dropped out
before the 14.5 year assessment), or administratively censored (completed the 14.5 year
assessment). Crude Kaplan-Meier survival curves, median age at menarche and inter-
quartile range [IQR: 25th–75th Percentile] estimates for the main exposure and all covariates
were obtained using life table analysis (SAS PROC LIFETEST). The difference in Kaplan-
Meier curves was evaluated using log-rank p-values (α = 0.05). We obtained adjusted
Kaplan-Meier curves and median age at menarche by exposure group by calculating inverse
probability-of-exposure weights31, 32 using polytomous logistic regression, and then
performing a weighted life table analysis.
Hazard ratios (HR) for menarche were estimated using Cox proportional hazards modeling.
The early formula group was used as the referent group in all models. Relative precision of
estimated HRs was compared using confidence limit ratios (CLR), calculated as the upper
95% confidence limit divided by the lower 95% confidence limit. The proportional hazards
assumption was assessed for all variables modeled, and continuous-time interaction terms
were included for variables in violation of this assumption (pre-pregnancy body mass index
(BMI) and maternal age at menarche). Potential outliers were identified using deviance
residuals (> ± 3) and dfbeta influence statistics (> 2/√n), and were excluded only in
explicitly identified sensitivity analyses. The HRs for our main exposure did not violate the
proportional hazards assumption according to the formal SAS diagnostics. They were not,
however, identical. To illustrate changes in the hazard ratios over time, a series of average
HRs for different periods of follow-up (11y, 12 y, 13 y, and complete duration of follow-up
(~14.5 y)) were estimated.33 Cox models were carried out using both complete case analysis
and multiple imputation (MI) analysis. For the complete case analysis, only subjects with
complete data on necessary covariates were modeled, which resulted in a loss of 18% of
subjects (n = 537). For the analyses including imputed data, values for missing outcome (n =
60) or necessary covariates were estimated from available data on all adjustment variables,
as well as birthweight, maternal education, maternal age at delivery, breast feeding duration,
marital status, child’s BMI and completion history for the menarche question on the
“Growing and Changing” questionnaires (based on which questionnaires contained negative
responses, which contained missing responses and which contained positive responses)
using SAS PROC MI (5 iterations). Cox models of imputed data were run and summarized
in SAS PROC MIANALYZE.
Covariates were included as confounders if they were associated with infant feeding method
and age at menarche or censoring in these data (via univariable association), or in relevant
literature, but not hypothesized to be along the causal pathway between infant feeding and
age at menarche. Variables examined included child’s birthweight, breast feeding duration,
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maternal report of milk allergy at 6 months, vegetarian diet/soy consumption in childhood,
maternal perception of infant health, prenatal vegetarian diet, maternal age at menarche, pre-
pregnancy BMI, prenatal smoking and maternal age and education at delivery. The final
models were adjusted for pre-pregnancy BMI, maternal report of smoking in the last 2
months of pregnancy (yes/no), and maternal age at menarche (continuous years).
To investigate the hypothesis that childhood BMI may be along the causal pathway between
infant feeding method and age at menarche, we estimated the association between feeding
group and BMI age-adjusted Z-scores34 using linear regression. Height and weight
measurements were obtained through either clinic visit or self-report between the ages of 7
and 9. The proportion of overweight girls in each feeding group was also compared using
chi-square tests (α = 0.05), where overweight was defined as having a BMI greater than the
85th percentile for age at any time between ages 7 and 9.
To complement the analysis described above, log-binomial regression was used to estimate
the risk of achieving early menarche, defined as < 12 years of age (11.9 years corresponds to
the 25th percentile for timing of menarche in non-Hispanic white females in the National
Health and Nutrition Examination Survey, 1988–199435). For censored subjects, those
censored after age 12 were included in the referent group, while those censored before age
12 were excluded (n = 473 (16%)).
Sensitivity Analyses
A set of sensitivity analyses were performed to assess whether proportional hazards model
results were affected by informative censoring.36 First, we assumed that all LTF subjects
were at low risk for reaching menarche in the study period, and their follow-up times were
reassigned to resemble the administratively censored (follow-up time: 175 months) (“low
risk”). In the second analysis, we assumed that LTF subjects were at high risk for reaching
menarche in the study period, and follow-up times were modeled as events occurring at the
time of drop out (“high risk”). Cox models were repeated for each hypothetical scenario,
with the resulting estimates representing extreme upper and lower bounds of the possible
influence of informative censoring on our results, were it to occur non-differentially across
exposure groups. In order to characterize potential differences in censoring across feeding
groups, chi-square tests, Fisher’s exact tests, and t-tests (α = 0.05) were used to compare
characteristics of LTF subjects to subjects who reported events or were administratively
censored.
RESULTS
Among 5,230 eligible ALSPAC subjects, 2,920 (56%) had sufficient infant feeding and
puberty data to be included in this analysis. Of the 2,310 excluded girls, 1,523 had
incomplete infant feeding profiles (n = 1,137 (49%)) or did not fit into a defined exposure
category (e.g., introduced to soy between 16 and 24 months, introduced to formula at 5
months, etc.) (n = 386 (17%)), 748 (32%) did not complete any “Growing and Changing”
questionnaire, and 39 (2%) did not report an age at menarche, as previously described. On
average, excluded girls had lower birthweight, were more likely to be ill as infants, exposed
to prenatal tobacco smoke, and born to younger, heavier mothers than those that remained in
the final study sample (Table 1). Excluded girls were also more likely to have missing data
on nearly all covariates examined. There were no differences between the included and
excluded subjects with respect to soy product use. However, excluded girls were less likely
to be classified in the primarily breast-fed group, had shorter breastfeeding duration, and
were more likely to be classified in the early formula group, as compared to the included
study sample.
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Early soy exposed girls were similar to early formula exposed girls with respect to
birthweight and childhood BMI, as well as maternal pre-pregnancy BMI, age at menarche,
prenatal smoking status, marital status, and prenatal vegetarian diet (Table 2). Early soy
exposed girls did experience longer breast feeding duration than early formula fed girls and
were more likely to continue a vegetarian diet/soy consumption in childhood. Additionally,
their mothers were more likely to be older at delivery, have higher education, and have
perceptions of poor infant health or infant milk allergy. Late soy and primarily breast fed
girls both differed from early formula fed girls with respect to breast feeding duration,
childhood BMI, childhood vegetarian diet/soy consumption; and maternal pre-pregnancy
BMI, age at delivery, education, prenatal smoking status, and prenatal vegetarian diet.
The median age at menarche for the study sample was 153 months (12.8 years) [IQR, 144–
163]. The median follow-up time contributed by those lost to follow up (n = 666 [22.8%])
was 140 months (11.7 years) [IQR, 117–157]. Nearly 2% of girls in the final study sample
(n = 54) were fed soy at or prior to 4 months of age (early soy). Over 20% of subjects in this
group initiated soy use in the first month, while approximately 37% initiated soy use at age 4
months. Three percent of all girls were administratively censored, suggesting that they
experienced menarche at some point after age 14.5 y. None of the administratively censored
were early soy fed.
In crude analyses, there was no difference in age at menarche between strata of birthweight,
maternal perception of infant health, or maternal age at delivery (Table 1), or of marital
status, maternal education, prenatal vegetarian diet, childhood vegetarian diet/soy
consumption, or maternal report of milk allergy at 6 months (not shown). Earlier age at
menarche was observed among girls with high BMI and among girls whose mothers had a
high pre-pregnancy BMI or a young age at menarche. Early censoring also occurred among
girls with high BMI, and among those whose mothers had high pre-pregnancy BMI
(respective median [IQR] follow-up times among lost to follow up subjects: 128 [115–141]
and 132 [124–141]). Age at menarche was slightly earlier among girls exposed to prenatal
tobacco smoke (log-rank p = 0.06), and was later among girls with mothers who had an
older age at menarche (Table 1). These results are similar to previously published
associations in this cohort.37
Across infant feeding groups, the crude median age at menarche was earliest for girls
receiving an early soy diet (149 months (12.4 years) [IQR, 140–159]), and latest among
those who were primarily breast-fed (154 months (12.8 years) [IQR, 145–165]). The crude
Kaplan Meier curves were not statistically different over time for any feeding group,
compared to the early formula referent (log-rank pearly soy = 0.12, plate soy = 0.82;
pprimarily breast = 0.07), and following adjustment, the median age for all groups shifted to
153 months, with the exception of primarily breastfeeding which remained at 154 months.
However, prior to approximately 150 months, crude and adjusted Kaplan Meier curves
(Figure 2a,b) suggest more menarche events in early adolescence in the early soy group, as
compared to all other feeding groups, despite nearly equivalent median ages.
Averaged across the full length of follow-up, the hazard of reaching menarche among girls
in the early soy feeding group was approximately 1.25 times [95% confidence interval (CI),
0.92, 1.71] that among girls in the early formula feeding group, adjusted for maternal pre-
pregnancy BMI, prenatal smoking, and maternal age at menarche (Table 3). A modest
reduction in hazard was associated with breast feeding (HR: 0.95 [95% CI, 0.84, 1.06]),
while no association was observed for late soy feeding, over the full length of follow up.
Associations were similar in crude analysis of all eligible subjects, and in crude complete
case analysis, but were slightly attenuated for early soy exposures when identified outliers
were removed (n = 14) (HR: 1.20 [95% CI, 0.87, 1.64]). In addition, results were similar for
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all exposure groups when multiple imputation was implemented to account for missing
covariates (MI HRearly soy: 1.22 [95% CI, 0.88, 1.70; MI HRlate soy: 1.06 [95% CI, 0.85,
1.32]; MI HRprimarily breast: 0.97 [95% CI, 0.87, 1.08]). Since childhood BMI z-scores and
overweight status were not significantly different between early soy and early formula
feeding groups, the association between early soy feeding and menarche was not likely
mediated by childhood BMI in this analysis.
To further characterize the variability of hazards over time, a series of average hazard ratios
for increasingly longer periods of follow-up are also shown in Table 3. For early soy
exposure, these serial HR estimates suggest an elevated risk of menarche in the earlier stages
of adolescence that decreased with increasing length of follow up. Late soy exposure was
associated with a decreased risk of menarche up to approximately 12 years, and
subsequently reached the null with increasing length of follow up. A small decrease in risk
was associated with primarily breastfeeding at each follow up interval. These findings are
similarly conveyed in adjusted KM curves (Figure 2b).
Loss to follow up in the early soy group tended to occur earlier in the study than in the other
feeding groups (median LTF follow up for early soy = 123 months [IQR: 99–141]), yet the
overall proportion of LTF in the early soy group (n = 8 (15%)) was less than other feeding
groups (e.g., n = 513 (24%) in early formula). The possible effect of LTF subjects on
reported effect estimates, were they to be non-differentially informative as opposed to
random, was assessed in sensitivity analyses. If LTF subjects were all “high risk” for
menarche, the HR estimate associated with early soy exposure for the full length of follow
up decreased to 1.07 [95 % CI, 0.80, 1.44], whereas if these subjects were all “low risk,” the
HR increased to 1.50 [95% CI, 1.08, 2.00]. However, while LTF subjects (Table 1),
particularly those in the early formula feeding group (supplemental Table A.1), do appear to
have older maternal age at menarche and a higher proportion of prenatal smoking than other
subjects, these characteristics would likely induce bias in opposing directions, suggesting
that LTF subjects are neither high nor low risk. Of note, early formula LTF subjects also
demonstrated a lower proportion of childhood overweight than other early formula subjects.
However, the proportion of missing for this variable was also substantially greater for LTF
subjects (n = 141 (27%) versus n = 215 (13%)), thus limiting accurate characterization of the
differences.
Early menarche (< 12 years) was reported for 599 (20%) of 2,920 subjects. In a complete
case analysis (n = 2,028), the adjusted risk ratios for early menarche [95% CIs] were 1.53
[1.07, 2.18], 0.64 [0.37, 1.11], and 0.98 [0.81, 1.17] for early soy, late soy and primarily
breastfeeding exposures, respectively, in comparison to the early formula referent.
DISCUSSION
In this study, over the full course of follow up, early life exposure to soy products was
associated with a small, imprecisely estimated increased risk of menarche, while the median
age at menarche did not differ substantially between any of the feeding groups. However,
variations in risk over time were evident in multiple approaches to analysis, including
survival curves, serial hazard ratios, and the estimation of early menarche risk, that suggest
that the risk of menarche associated with early soy exposure was greatest in the early stages
of adolescence. This change in risk over time likely reflects both statistical and biological
phenomenon. Regardless of exposure status, the nearly all girls reach menarche at later
stages of follow up. Accordingly, the risk ratio of menarche for time points later in
adolescence is expected to approach 1.0, and therefore the HR averaged over the full course
of follow up is lower than it is for shorter periods of follow up. In addition, it is possible that
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biological susceptibility to soy among a sensitive subset of exposed girls would result in
elevated hazards in early, but not late adolescence, as we observed here.
An association between early soy exposure and early menarche is biologically plausible. The
physiological processes that regulate the onset of puberty are complex, and may have origins
in the fetal or neonatal periods. For example, the hypothalamic-pituitary-gonadal (HPG) axis
regulates hormone signaling that eventually leads to ovulation and menarche during puberty.
This system, which integrates the central nervous system and the reproductive tract, is also
active during the mid-fetal and infant stages of human development.38 Estrogen receptors
are present in the hypothalamus,39, 40 suggesting that this region in particular may be
susceptible to isoflavone binding. Accordingly, rodent models have demonstrated that
neonatal exposure to estrogenic compounds has altered hypothalamic characteristics and
function.17 In addition, recent evidence has suggested that manganese, which is found in
marginally higher concentrations in soy formula than in cow’s milk formula,41 may be
associated with hypothalamic function and early pubertal onset.42, 43 Although this
mechanism was not considered in our original study hypothesis, it may warrant further
exploration.
In general, we observed that early soy fed infants and their mothers were not readily
distinguishable from those in the early formula referent group with respect to demographic
and other descriptive characteristics. Importantly, the few characteristics by which these
feeding groups differed, including maternal age, education, breastfeeding duration, and child
health and diet, were not shown to be associated with age at menarche and therefore should
not bias our findings. For the remaining characteristics evaluated, early formula and early
soy exposure groups were similar.
A mild and particularly unstable decrease in hazard of menarche in early adolescence within
the late soy feeding group was also observed. That early soy and late soy feeding were not
similarly associated with age at menarche suggests that dose and timing of soy exposure
may be important for the induction of developmental effects. The exact amount of soy intake
in our sample is unknown, so a true dose-response relationship could not be assessed.
However, since the diet becomes increasingly diverse with increasing age, exposure to soy
formula is presumably higher during early infancy as compared to later, possibly influencing
the observed associations. In addition, since early formula and late soy feeders were found
to consistently differ on most demographic and lifestyle characteristics, there is increased
potential for residual confounding in early formula and late soy comparisons, relative to
early formula and early soy comparisons. Thus, late soy exposure findings should be
interpreted with particular caution.
Strom et al.24 reported on various endocrine-sensitive outcomes among adults who had
participated in cow’s milk formula and soy formula clinical trials in infancy, and observed
no difference in recalled age at menarche between the two feeding groups (adjusted mean
difference in years = -0.03 [95% CI, –0.32,0.26]). We also noted little difference in the
median age at menarche over the full course of this study. However, using survival analysis,
we did observe that early soy exposed girls were at higher risk of menarche in early
adolescence. This finding reflects a subtle characteristic of the association between soy
infant feeding and menarche that was not captured in previous studies.
The longitudinal nature of our study was advantageous in that it allowed for age at menarche
to be repeatedly assessed and estimated within approximately 1 year of the menarche event
through age 14.5. There is potential, however, for selection bias in our final study sample,
particularly if there is a characteristic that was associated with infant feeding method, age at
menarche and inclusion in our final study sample. As stated previously, excluded girls had
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lower birthweight, shorter breast feeding duration, were more likely to be ill as infants,
exposed to prenatal tobacco smoke, and born to younger, heavier mothers. However, none of
these characteristics were differentially associated with early soy and early formula feeding,
and with age at menarche, so the associations observed among early soy fed girls are not like
to be biased due to selection in this way. However, it is possible that other unmeasured
factors may have influenced participation in the study and may have allowed for some
selection bias to persist.
Given the distribution of predictive characteristics such as maternal age at menarche, pre-
pregnancy BMI, and prenatal smoking among the LTF subjects (Table 1, supplemental
Table A.1), there is no clear indication that informative censoring is present in this analysis
that would result in biased estimates. For early formula fed girls specifically, the
characteristics for which differences were observed between LTF and other subjects would
not likely induce bias in a consistent direction (i.e., the net bias may be minimal given that
estimates may be both over and underestimated due to a higher proportion of prenatal
smoking and older maternal age at menarche, respectively, in the LTF). In addition, we
adjusted for maternal age at menarche and prenatal smoking to control for bias related to
LTF. Still, sensitivity analyses demonstrated that our results do have the potential to be
biased by informative censoring, were this type of censoring to be present, non-differentially
by exposure status. Of particular concern, the “high risk” model yielded estimates for early
soy exposure that were nearly null. While this model is an unrealistic treatment of our
data,36 it is important to consider that our estimates may be overestimating the true
association between early soy feeding and age at menarche due to censoring, and replication
of our findings is imperative before meaningful conclusions can be drawn.
This analysis was conducted using a large, longitudinal cohort study that is generalizable to
the United Kingdom.44 This cohort is unique in that it allows investigators to relate early life
exposures to adolescent outcomes, without the hindrance of inaccurate, long term recall.
However, although ALSPAC is large, we had only 54 girls in the early soy group, which
limited the power and precision of our analysis. Our analysis was also restricted to white
girls, and our final study sample differed from excluded ALSPAC participants on multiple
characteristics, such as prenatal tobacco smoke exposure and maternal age at delivery.
Lastly, it is unclear if the infant formula products used in the UK at this time were
substantially different from those used, for example, in the United States in the present day.
Therefore, the generalizability of these results may be limited.
In summary, our study yielded preliminary findings that exposure to soy products in early
infancy may contribute to a small increase in risk of menarche in early adolescence. This
study contributes to a growing literature on the potential for endocrine disruptors to affect
pubertal onset, making use of a uniquely wide exposure contrast between those who were
and were not fed soy products in infancy. However, additional research is needed given the
limitations of our study, such as low prevalence of exposure and large loss to follow up in
our study sample. Future studies in populations with higher soy formula prevalence, such as
in the United States, will be informative.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Study Sample and Exposure Characterization. Subjects were classified into four mutually
exclusive feeding groups (primarily breast, early formula, early soy, late soy) based on age
and duration of formula, milk and breastmilk feeding. Boxes contain the final study sample
size, by exposure group, for subjects with complete exposure and outcome data. aother:
formula/baby milk, goat’s milk, hypo-allergenic formula, follow-on milk, and cow’s
milk. bunknown: data was insufficient to determine breast feeding duration or milk/formula
use through 6 months. csoy: soy milk or soy formula. m: months.
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Crude (a) and counfounding-adjusted (b) Kaplan Meier survival curves for each feeding
group are shown above. Censored observations are indicated by ◦. Survival for each feeding
group is incidated as follows:  early formula;  early soy;  late soy; 
primarily breast. Confounding-adjusted curves are adjusted for pre-pregnancy BMI,
maternal age at menarche, and prenatal smoking using inverse probability of treatment
weights estimated with polytomous logistic regression.
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Table 1
Characteristics of eligiblea ALSPAC study sample (n = 5,230), distinguished as those included in the present
analysis (n = 2,920) and those excluded for missing exposure or outcome data (n = 2,310)
Study Sample Included in Present Analysis Excluded
n (%) Median Age at Menarche
(m) [IQRb]
Lost to Follow Upc
n (%)
n (%)
Study Sample 2920 153 [144 – 163] 666 2310
Feeding Group
      Early Formula 2124 (72.7) 153 [144–163] 513(77.0) 607 (77.1)*
      Early Soy 54 (1.9) 149 [140–159] 8 (1.2) 12 (1.5)
      Late Soy 111 (3.8) 153 [147–159] 21 (3.2) 30 (3.8)
      Primarily Breast 631 (21.6) 154 [145–165] 124 (18.6) 138 (17.5)*
      Missing -- -- -- 1523
Birthweight
      ≤ 2500g 36 (1.2) 151 [146–160] 10 (1.5) 52 (2.3)*
      >2500g 2843 (98.8) 153 [144–163] 646 (98.5) 2231 (97.7)*
      Missing 41 153 [144–161] 10 27
    Mean ±SD (g) 3439 ± 436 - 3464 ±460 3408 ±464*
Breast Feeding Duration
    Mean ± SD (m) 4.3 ±4.6 - 3.7 ±4.4 3.7 ± 4.4*
      Missing 0 - 0 142
Pre-pregnancy BMI
      ≥ 25 538 (20.0) 150 [141–160] 128 (21.1) 433 (21.8)
      < 25 2156 (80.0) 154 [145–164] 478 (78.9) 1552 (78.2)
      Missing 226 154 [144–162] 60 325
      Mean ±SD 22.8 ±3.7 - 23.0 ± 4.0 23.1 ± 4.0*
Maternal Age at Menarche
      8–11 493 (19.1) 147 [138–155] 98 (16.9) 376 (19.6)
      12–14 1771 (68.6) 154 [145–163] 389 (67.1) 1276(66.6)
      15+ 317 (12.3) 161 [151–171] 93 (16.0) 263 (13.7)
      Missing 339 154 [145–165] 86 395
    Mean ± SD (y) 12.8 ±1.5 - 12.8 ± 1.5 12.8 ± 1.6
Prenatal Smoking
      Yes 423 (14.8) 152 [142–163] 128 (20.2) 419 (21.2)*
      No 2433 (85.2) 154 [144–163] 506 (79.8) 1559 (78.8)*
      Missing 64 153 [147–160] 32 332
BMI, age 7–9
      >85th Percentile 613 (24.8) 148 [137–155] 92 (19.1) 270 (24.4)
      ≤ 85th Percentile 1856 (75.2) 156 [147–165] 389 (80.9) 835 (75.6)
      Missing 451 154 [143–162] 185 1205
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Study Sample Included in Present Analysis Excluded
n (%) Median Age at Menarche
(m) [IQRb]
Lost to Follow Upc
n (%)
n (%)
Infant Health at 6 months
      Healthy/ Minor Problems 2781 (98.0) 153 [144–163] 617 (96.9) 1777 (96.4)*
      Sometimes Ill/Unwell 56 (2.0) 153 [148–170] 20 (3.1) 66 (3.6)*
      Missing 83 154 [144–160] 29 467
Maternal Age at Delivery
      ≤ 30 1942 (66.5) 154 [144–163] 477 (71.6) 1674 (72.5)*
      >30 978 (33.5) 153 [144–164] 189 (28.4) 636 (27.5)*
      Missing 0 - 0 0
    Mean ± SD (y) 28.8 ±4.5 - 28.1 ± 4.7 27.6 ± 5.0*
*
p < 0.05, comparing proportion or mean of excluded to proportion or mean of included.
a
Term, singleton, white females born in the ALSPAC cohort.
b
Interquartile Range: 25th – 75th Percentile
c
Subjects who completed at least one “Growing and Changing” questionnaire, but did not report menarche and did not complete the “Growing and
Changing” questionnaire administered at 14.5 years; a subset of study sample (n = 2,920).
m: months; y: years
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Table 2
Distribution of characteristics (mean ± SD for continuous variables, n (%) for categorical variables) by feeding
group
Early Formula Early Soy Late Soy Primarily Breast
n 2124 54 111 631
Mean ± SD
Birthweight (g) 3426 ± 436 3479 ± 528 3527 ± 435* 3462 ± 422
      Missing, n 30 1 1 9
Breastfeeding Duration (m) 2.4 ± 3.0 4.1± 4.3* 7.4 ± 4.8* 10.5 ± 3.0*
      Missing, n 0 0 0 0
Pre-pregnancy BMI 23.1 ± 3.9 22.9 ± 4.1 22.1 ± 3.8* 22.3 ± 3.0*
      Missing, n 166 3 7 50
Maternal Age at Menarche (y) 12.8 ± 1.5 12.5 ± 1.3 13.1 ± 1.6 13.0 ± 1.5*
      Missing, n 258 6 13 62
Maternal Age at Delivery (y) 28.3 ± 4.4 30.6 ± 5.0* 29.7 ± 4.4* 30.2 ± 4.4*
      Missing, n 0 0 0 0
Age-adjusted BMI z -score, age 7 0.21 ± 0.96 0.24 ± 1.23 −0.02 ± 0.86* 0.04 ± 0.96*
      Missing, n 513 9 19 106
Age-adjusted BMI z -score, age 8 0.35 ± 0.90 0.51 ± 0.86 0.13 ± 0.78* 0.17 ± 0.93*
      Missing, n 638 18 32 157
Age-adjusted BMI z -score, age 9 0.24 ± 0.96 0.47 ± 0.92 0.01 ± 0.96 −0.01 ± 1.02*
      Missing, n 919 19 48 220
n (%)
Prenatal Smoking
      Yes 361 (17) 9 (17) 10 (9)* 43 (7)*
      No 1712 (83) 45 (83) 99 (90) 577 (93)
      Missing, n 51 0 2 11
Perceived Infant Health
      Healthy/Minor Problems 2038 (98) 43 (86)* 105 (99) 595 (99)
      Sometimes Ill/Unwell 39 (2) 7 (14) 1 (1) 9 (1)
      Missing, n 47 4 5 27
Marital Status
      Single 348 (17) 10 (20) 13 (12) 71 (12)*
      Married 1705 (83) 41 (80) 96 (88) 540 (88)
      Missing, n 71 3 2 20
Maternal Educationa
      O-Level, Voc, CSE, None 1300 (64) 23 (43)* 40 (36)* 264 (43)*
      A-Level, Degree 744 (36) 30 (57) 70 (64) 349 (57)
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Early Formula Early Soy Late Soy Primarily Breast
      Missing, n 80 1 1 18
BMI, age 7–9
      Ever > 85th Percentile 465 (26) 17 (35) 13 (13)* 118 (21)*
      Never > 85th Percentile 1303 (74) 32 (65) 86 (87) 435 (79)
      Missing, n 356 5 12 78
Vegetarian/Soy Diet in Childhood
      Yes 44 (3) 5 (11)* 14 (14)* 33 (6)*
      No 1718 (97) 39 (89) 85 (86) 519 (94)
      Missing, n 362 10 12 79
Milk Allergy at 6 m
      Yes 21 (1) 26 (50)* 16 (15)* 6 (1)
      No 2063 (99) 26 (50) 90 (85) 601 (99)
      Missing, n 40 2 5 24
Prenatal Vegetarian Diet
      Yes 97 (5) 5 (9) 16 (15)* 55 (9)*
      No 2005 (95) 49 (91) 93(85) 564 (91)
      Missing, n 22 0 2 12
m: months; y: years
a
Levels of education, ranked lowest to highest: None, CSE (Certification of Secondary Education), Voc (Vocational), O-Level (Ordinary Level),
A-Level (Advanced Level), and Degree (University Degree).
*
p <0.05, compared to early formula feeding group
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